Navigation Links
U.S. Experts Still Unsure of Allergy Relief by Mouth
Date:11/6/2008

Medicines in droplet or pill form aren't yet ready to replace injections, physicians say

THURSDAY, Nov. 6 (HealthDay News) -- Even though orally delivered "sublingual immunotherapy" (SLIT) is used to treat allergies in a number of countries, there are unanswered questions about its effectiveness, appropriate use, dosage and safety of administration, according to experts at the annual meeting of the American College of Allergy, Asthma & Immunology (ACAAI), in Seattle.

SLIT -- a therapy considered investigational in the United States -- involves absorption of allergens into the body through the membranes of the mouth. Like traditional allergy injections, this is designed to help the body fight specific allergens.

"The main advantage of SLIT over traditional immunotherapy is patient convenience, since it is not an injection but oral drops or tablets that can be administered at home, and it appears to be safer than conventional immunotherapy," Dr. Ira Finegold, clinical professor of medicine at Columbia University and chairman of the R.A. Cook Institute of Allergy, St. Luke's-Roosevelt Hospital in New York, said in an ACAAI news release.

"Sublingual immunotherapy has gained wide acceptance in the treatment of allergic disease throughout Europe and South America, but the research studies in the United States have yet to show results that will convince the FDA to approve a product," Finegold said.

"We do not know the optimal dose for U.S. licensed allergen extracts for SLIT," added Dr. Linda Cox, assistant clinical professor of medicine at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Fla. "There is no consistent relationship between allergen dose and clinical efficacy. Each formulation including U.S. licensed extracts will need to demonstrate its effective dosing regimen."

She noted that since "SLIT treatment is administered at home with no direct medical supervision, the physician will need to provide specific instructions to patients on how to manage adverse reactions, unplanned treatment interruptions, situations in which the dose should be withheld, and dosing adjustments for any or all of these variables."

More information

The American Academy of Family Physicians has more about allergies.



-- Robert Preidt



SOURCE: American College of Allergy, Asthma & Immunology, news release, Nov. 6, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. USAID Sends Additional Earthquake Assistance and Team of Experts to Pakistan
2. Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy
3. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
4. Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders
5. Children's National Experts Presenting at American Academy of Pediatrics Conference
6. Local Experts Help Women Living and Working with Cancer Even the Score
7. Save Money, Lives, and the Earth by Combining Conservation and Family Planning, Say Experts at World Conservation Congress
8. Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting, Oct. 25-29
9. PFCD Experts Cite Health Care as Next Financial Casualty on Horizon
10. Autism, Learning Disabilities and ADHD Experts Convene at the Help Group Summit
11. Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Experts Still Unsure of Allergy Relief by Mouth
(Date:3/27/2017)... , ... March 27, 2017 , ... The homeowner improvement ... number of homeowners utilizing DIY and unlicensed contractors for renovations is also on the ... replacement project in 2015, and of those, 42% failed to use a licensed contractor.(2) ...
(Date:3/24/2017)... ... March 24, 2017 , ... Clean Earth, Inc., a ... hazardous and non-hazardous materials announced today the acquisition of privately owned AERC ... four additional processing facilities and a vast array of additional technologies, services, and ...
(Date:3/24/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) has named ... in their 12th year, are among the most prestigious in radiology marketing because a ... were retooled to recognize achievements in both large budget (over $5,000) and small budget ...
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic ... Center for Shamanic Healing and Spiritual Awakening, proudly presents her Sacred Peru ... This sacred and spiritual journey during the Summer Solstice will also be ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the firm ... the firm, will concentrate her practice in elder law, Medicaid planning and applications, and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 report ... of deep learning solutions within the healthcare domain. Primarily driven by ... novel solution to generate relevant insights from medical data. ...
(Date:3/24/2017)... 24, 2017  GenomeDx Biosciences today announced that six ... Decipher® Prostate Cancer Classifier tests will be presented at ... (EAU) Congress held March 24 to 28, 2017 in ... Congress is Europe,s largest urological ... the urological field. The abstract titled "Muscle ...
(Date:3/24/2017)... YORK and GENEVA , ... announced on World Tuberculosis Day revitalizes efforts to develop ... On World Tuberculosis Day, TB Alliance and ... for the clinical development of sutezolid, an antibiotic drug ... sublicense pertains to the development of sutezolid in combination ...
Breaking Medicine Technology: